Did you know that we are aging at the psychological level and there is a way to think, feel, and behave as a younger individual? Check out this Forbes article if you would like to learn more about the psychology of aging. And here is an excerpt from William Shakespeare’s…

During our 5-year journey, we tried many things, made many mistakes, and got famous in several industries primarily due to our commitment to leadership in technology and open collaboration. We did not take an easy route, where you turn the idea into a business plan, hire several big names, and…

For the many experts in AI, pharma, and longevity industries who know our team well the recent announcement of our $37 million round may come as no surprise. We are the original inventors of some of the critical technologies that make it possible to identify and prioritize disease targets in…

9月10日，香港 — — AI药物研发公司Insilico Medicine日前完成了3700万美元的B轮融资，启明创投领投，斯道资本、F-Prime Capital、礼来亚洲基金、创新工场、百度风投、兰亭投资、BOLD Capital Partners等其他投资方（包括A轮投资方）跟投。 Insilico Medicine是利用新一代人工智能技术进行药物发现的领军企业。本轮募集的资金将用于产业化其小分子设计平台以及靶点发现平台，组建具有丰富制药行业经验的管理团队，通过与其他大型制药公司合作的模式进一步开发其在癌症、纤维化、NASH、免疫学和中枢神经系统疾病等方面的产品管线。 Insilico Medicine开发和验证了一套可供生成模型以及机器学习的算法，用来设计生成小分子靶向药物。同时公司还能通过其靶点发现平台找到在癌症、纤维化、NASH、免疫学和中枢神经系统疾病等方面的靶点。在商业模式上，Insilico Medicine通过与早期的生物技术公司以及大型生物制药公司的合作来推动数字时代医药行业的发展。

Original press release by Qiming Venture Partners Tuesday, September 10, Hong Kong — Insilico Medicine, a pioneer in next-generation artificial intelligence technology for drug discovery, recently completes a $37 million funding round led by Qiming Venture Partners, joined by Eight Roads, F-Prime Capital, Lilly Asia Ventures, Sinovation Ventures, Baidu Ventures…

Paper reference: The Advent of Human Life Data Economics Recent advances in artificial intelligence and precision medicine led to the emergence of new businesses that trade and process human health data. Most pharmaceutical companies are acquiring large volumes of clinical and other data for research and marketing purposes. However, there…

There is no better feeling than being firmly convinced that you are doing the right thing in life. This is the comfort provided by most religions. …

On Monday, February 4th, 2019 the Big Data Institute announced a new doctoral training program: https://www.bdi.ox.ac.uk/news/bdi-to-host-epsrc-centre-for-doctoral-training-in-health-data-science Insilico Medicine is happy to contribute to this wonderful initiative. The University of Oxford is considered to be #1 in the world in artificial intelligence and now we know why. …

I would like to congratulate our investors, friends, business partners, and fellow longevity biotechnology experts at Juvenescence on the first close of their series B. The company now raised over $100 million and turned into a household name in the longevity biotechnology community. …